Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
1,086
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

The Effect of Zbxz23ir-21 NANO(nanomaterials) Delivery Vector on Apoptosis and PTEN(phosphatase and tensin homolog deleted on chromosome ten)/PI3K(Intracellular phosphatidylinositol kinase)/AKT(related to the A and C kinase) in Children with CHOLESTEATOMA in Middle Ear

Hongwei ZhengDepartment of Otolaryngology, Peking University People’s Hospital, Beijing, ChinaView further author information
,
Wenlun WangDepartment of Otolaryngology, Peking University People’s Hospital, Beijing, ChinaView further author information
,
Shichang LiDepartment of Otolaryngology, Peking University People’s Hospital, Beijing, ChinaView further author information
&
Lin HanDepartment of Otolaryngology, Peking University People’s Hospital, Beijing, ChinaCorrespondence[email protected]
View further author information
Pages 8809-8821 | Received 04 Aug 2021, Accepted 20 Sep 2021, Published online: 26 Oct 2021

References

  • Youngren-Ortiz SR, Gandhi NS, Espaa-Serrano L, et al. Aerosol delivery of siRNA to the lungs. Part 2: nanocarrier-based delivery systems[J]. Kona Powder Sci Technol Japan. 2017;34(34):44.
  • Liu C, Cheng F, Yang X. Fabrication of a soybean Bowman-Birk Inhibitor (BBI) nanodelivery carrier to improve bioavailability of curcumin[J]. J Agric Food Chemistry. 2017;65(11):2426–2434.
  • Chakraborty A, Dhar. P. A review on potential of proteins as an excipient for developing a nano-carrier delivery system.[J]. Crit Rev Ther Drug Carrier Syst. 2017;34(5):453.
  • Sree K, V Ruchi, PK Girish, K Lalit. A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization. Int J Nanomedicine. 2017;12:15–28.
  • Yu D, Wang X, Jiang R. Progress in antitumor nano-drug carrier[J]. Tumor. 2018;38(6):603–609.
  • Baruah RR, Kalita MC, Devi D. Novel non-mulberry silk fibroin nanoparticles with enhanced activity as potential candidate in nanocarrier mediated delivery system[J]. RSC Adv. 2020;10(15):9070–9078.
  • Su C, Y Liu, R Li, W Wu, J Gu. Absorption, distribution, metabolism and excretion of the biomaterials used in Nanocarrier drug delivery systems. Adv Drug Deliv Rev. 2019;143:97–114.
  • Patil JS, Naik JB. Carrier based oral nano drug delivery framework: a review[J]. Curr Nanomater. 2018;3(2):75–85.
  • Marziyeh, Fathi, Parham, Sahandi, Zangabad, Jaleh, Barar, Ayuob, Aghanejad, Hamid. Thermo-sensitive chitosan copolymer-gold hybrid nanoparticles as a nanocarrier for delivery of erlotinib. Int J Biol Macromol Struct Funct Interact. 2018;106:266–276.
  • Behzad M, Maysam P, Ebrahim GZ. An improved method for magnetic nanocarrier drug delivery across the cell membrane[J]. Sensors. 2018;18(2):381.
  • Yangyang, Liu, Yancai, Wang, Juan, Zhao. Design, optimization and in vitro-in vivo evaluation of smart nanocaged carrier delivery of multifunctional PEG-chitosan stabilized silybin nanocrystals. Int J Biol Macromol. 2018;124:667–680.
  • Xie S, Wang X, Ren J, et al. The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma[J]. Eur Arch Oto Rhino Laryngol. 2017;274(5):2071–2078.
  • Rcsa B, CCLC D, WAB Na, XTFA B, SHHA B, ZAB Jie, LXHA B, XZZ E, ATXA B. TFIIB-related factor 2 regulates glucose-regulated protein 78 expression in acquired middle ear cholesteatoma. Biochem Biophys Res Commun. 2021;540:95–100.
  • Nagel J, W?llner S, Schürmann M, et al. Stem cells in middle ear cholesteatoma contribute to its pathogenesis[J]. Sci Rep. 2018;8(1):6204.
  • Yamamoto-Fukuda T, N Akiyama, M Takahashi，H Kojima. Keratinocyte Growth Factor (KGF) modulates epidermal progenitor cell kinetics through activation of p63 in middle ear cholesteatoma[J]. J Assoc Res Otolaryngology. 2018;19(3):223–241.
  • Sharma SD, A Hall, AC Bartley, P Bassett, RK Lingam. Surgical mapping of middle ear cholesteatoma with fusion of computed tomography and diffusion-weighted magnetic resonance images: diagnostic performance and interobserver agreement. Int J Pediatr Otorhinolaryngol. 2019;129:109788.
  • Jeong H, DH Lee, JE Shin, CH Kim. Positional nystagmus in middle ear cholesteatoma with labyrinthine fistula. Med Hypotheses. 2020;144:110223.
  • Karamert R, Fakih, Cihat, Eravc, Süleyman, Cebeci, Mehmet, Düzlü, Mehmet. Canal wall down versus canal wall up surgeries in the treatment of middle ear cholesteatoma[J]. Turk J Med Sci. 2019;49(5):1426–1432.
  • Xie S, Wei L, Ren J. Reply to the Letter to the Editor regarding “Etiopathogenesis of bone resorption in acquired middle ear cholesteatoma”[J]. Archiv für Klinische und Experimentelle Ohren- Nasen- und Kehlkopfheilkunde. 2017;274(12):4253.
  • Wang R, X Zheng, L Zhang, B Zhou, H Hu, Z Li, L Zhang, Y Lin, X Wang. Histone H4 expression is cooperatively maintained by IKKβ and Akt1 which attenuates cisplatin-induced apoptosis through the DNA-PK/RIP1/IAPs signaling cascade. Rep. 2017;7:41715.
  • Long S, Hongfeng L,  Biao Q, Wei Z,  Jing J, Xujun L. MiRNA-10a-3p enhanced cell apoptosis by regulating pten/pi3k/akt signaling pathway in breast cancer[J]. Acta Med Mediterr. 2020;36(2):901–906.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.